Virtual Global Summit
How I Treat Gallbladder and Bile Duct Cancer in 2026: OncoDaily Virtual Summit
Overview
Event Highlights
- Early and accurate diagnosis remains essential, with expert pathology, careful staging, and molecular testing playing a central role in guiding treatment decisions.
- Surgery continues to offer the best chance of cure for localized disease, while robotic and minimally invasive techniques are expanding options in experienced hepatobiliary centers.
- Comprehensive genomic profiling is increasingly important in advanced biliary tract cancer, helping identify actionable alterations such as HER2, FGFR2, IDH1, and RAS.
- Immunotherapy and targeted therapies are transforming systemic treatment, creating more personalized options for patients who historically had limited alternatives.
- Improving outcomes requires strong multidisciplinary collaboration and more equitable access to molecular testing, specialized expertise, clinical trials, and new treatments across healthcare systems worldwide.
Event Series
Date / Time
Feb 28, 2026 · 10:00 AM – 10:00 PM
The OncoDaily Gallbladder and Bile Duct Cancer Summit 2026 was a global virtual medical congress dedicated entirely to gallbladder and bile duct cancers, with a focus on screening, early diagnosis, multidisciplinary treatment strategies, and future directions in prevention and disease control.
Held on February 28 during Gallbladder and Bile Duct Cancer Awareness Month, the summit brought together leading experts from across continents to discuss current standards of care, emerging therapies, precision medicine approaches, and evolving clinical practices shaping the future of hepatobiliary oncology.
Who Attended and What the Summit Covered
The OncoDaily Gallbladder and Bile Duct Cancer Summit 2026 was designed for medical oncologists, hepatobiliary surgeons, gastroenterologists, radiation oncologists, radiologists, pathologists, translational researchers, and oncology trainees seeking a practical and globally informed perspective on gallbladder and biliary tract cancer management in 2026.
The meeting emphasized evidence-based decision-making, multidisciplinary coordination, surgical innovation, and the integration of emerging systemic therapies into real-world clinical practice.
By bringing together experts from different regions, the summit addressed variations in access to care, diagnostic capabilities, and treatment strategies, while highlighting future directions in hepatobiliary oncology.
The event delivered a dedicated day of discussion focused on gallbladder and bile duct cancer science, clinical strategy, surgical advances, and global perspectives, featuring expert voices from across continents.
Scientific Program
This focused virtual meeting explored the full clinical spectrum of gallbladder and biliary tract cancers, emphasizing practical, experience-based management in 2026.
The program addressed contemporary approaches to suspected and early-stage gallbladder cancer through risk-stratified decision-making, as well as evidence-based strategies for advanced and metastatic disease.
Sessions examined the structured treatment principles guiding daily clinical practice, including systemic therapy selection, multidisciplinary coordination, and individualized patient care.
The summit also highlighted evolving surgical standards, including minimally invasive and robot-assisted techniques for gallbladder and bile duct cancers.
Throughout the discussions, speakers shared real-world perspectives on optimizing outcomes, integrating innovation into clinical practice, and shaping the future direction of hepatobiliary oncology across diverse healthcare settings worldwide.
Scientific Program
This focused virtual meeting explored the full clinical spectrum of gallbladder and biliary tract cancers, emphasizing practical, experience-based management in 2026.
The program addressed contemporary approaches to suspected and early-stage gallbladder cancer through risk-stratified decision-making, as well as evidence-based strategies for advanced and metastatic disease.
Sessions examined the structured treatment principles guiding daily clinical practice, including systemic therapy selection, multidisciplinary coordination, and individualized patient care.
The summit also highlighted evolving surgical standards, including minimally invasive and robot-assisted techniques for gallbladder and bile duct cancers.
Throughout the discussions, speakers shared real-world perspectives on optimizing outcomes, integrating innovation into clinical practice, and shaping the future direction of hepatobiliary oncology across diverse healthcare settings worldwide.
